Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl- N-nitrosourea: Direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchored protein expression
► We developed a flow cytometric Pig-a assay for measuring gene mutation in the mouse. ► We used this assay to elucidate the generation of mutations in the Pig-a assay. ► The kinetics of Pig-a mutant manifestation is more rapid in bone marrow than in peripheral blood. ► CD24-negative erythroids have...
Saved in:
Published in | Mutation research Vol. 723; no. 1; pp. 36 - 42 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
14.07.2011
Elsevier Elsevier BV |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ► We developed a flow cytometric
Pig-a assay for measuring gene mutation in the mouse. ► We used this assay to elucidate the generation of mutations in the
Pig-a assay. ► The kinetics of
Pig-a mutant manifestation is more rapid in bone marrow than in peripheral blood. ► CD24-negative erythroids have mutation in the
Pig-a gene. ► The
Pig-a assay on red blood cells is useful for the detection of
in vivo mutagenicity.
Our previous rat studies indicate that the endogenous
Pig-a gene is a promising reporter of
in vivo mutation and potentially useful as the basis for an
in vivo genotoxicity assay. The function of the Pig-a protein in the synthesis of glycosylphosphatidyl inositol (GPI) anchors is conserved in variety of eukaryotic cells, including human and rodent cells, which implies that
Pig-a mutants can be measured in a similar manner in different mammalian species. In the present study, we developed a flow cytometric
Pig-a assay for rapidly measuring gene mutation in the mouse. An antibody to TER-119, a specific cell-surface marker of murine erythroid lineage, was used to identify erythrocytes in peripheral blood (PB) and erythroids in bone marrow (BM). An antibody to CD24, a GPI-anchored protein, was used to identify
Pig-a mutants as CD24-negative cells. CD-1 mice were administered a single dose of 100
mg/kg
N-ethyl-
N-nitrosourea (ENU), and PB and BM were collected at 1, 2, and 4 weeks after dosing. While the
Pig-a mutant frequency (MF) in PB was increased moderately at 2 and 4 weeks after ENU dosing, the
Pig-a MF in BM was strongly increased starting at 1 week after the dosing, with the elevated MF persisting for at least 4 weeks after the dosing. We also used flow cytometric sorting to isolate CD24-negative erythroids from the BM of ENU-treated mice. cDNA sequencing indicated that these cells have mutations in the
Pig-a gene, with base-pair substitutions typical of ENU-induced mutation spectra. The results indicate that the
Pig-a mutation assay can be adapted for measuring mutation in BM erythroids and PB of mice. Taken together, the data suggest that
Pig-a mutants are fixed in the BM, where they further proliferate and differentiate; erythrocytes derived from these BM
Pig-a mutants transit from the BM and accumulate in PB. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 1383-5718 0027-5107 1879-3592 |
DOI: | 10.1016/j.mrgentox.2011.03.016 |